Literature DB >> 3490954

Corneal penetration of topical amphotericin B and natamycin.

D M O'Day, W S Head, R D Robinson, J A Clanton.   

Abstract

The corneal uptake and penetration of 14C-labelled 0.15% amphotericin B and 5% natamycin were studied in Dutch-belted rabbits. Corneal levels of natamycin were substantially higher than amphotericin B. For both drugs, these levels were influenced by corneal contact time. In corneas debrided of epithelium, both agents entered the corneal stroma and levels were detected in aqueous in the therapeutic range. However, in corneas with intact epithelium, penetration was negligible for amphotericin B (0.23 microgram/gm at 2 mins). By contrast, although penetration of natamycin was greatly reduced, 7.0 micrograms/gm were present at 2 mins.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3490954     DOI: 10.3109/02713688609029240

Source DB:  PubMed          Journal:  Curr Eye Res        ISSN: 0271-3683            Impact factor:   2.424


  35 in total

1.  A presentation of culture-positive corneal donors and the effect on clinical outcomes.

Authors:  Aida Hajjar Sesé; Jens Lindegaard; Hanne Olsen Julian; Klavs Højgaard-Olsen; Niels Frimodt Møller; Steffen Heegaard
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2018-11-30       Impact factor: 3.117

2.  Cell penetrating peptides as efficient nanocarriers for delivery of antifungal compound, natamycin for the treatment of fungal keratitis.

Authors:  Aastha Jain; Sushmita G Shah; Archana Chugh
Journal:  Pharm Res       Date:  2014-12-03       Impact factor: 4.200

3.  Voriconazole concentration in human aqueous humor and plasma during topical or combined topical and systemic administration for fungal keratitis.

Authors:  Michael A Thiel; Annelies S Zinkernagel; Jürgen Burhenne; Claude Kaufmann; Walter E Haefeli
Journal:  Antimicrob Agents Chemother       Date:  2006-10-23       Impact factor: 5.191

Review 4.  Update on the Management of Infectious Keratitis.

Authors:  Ariana Austin; Tom Lietman; Jennifer Rose-Nussbaumer
Journal:  Ophthalmology       Date:  2017-09-21       Impact factor: 12.079

5.  Clinical results of topical fluconazole for the treatment of filamentous fungal keratitis.

Authors:  Sergio Sonego-Krone; Daniel Sanchez-Di Martino; Rosa Ayala-Lugo; Guillermo Torres-Alvariza; Christopher N Ta; Luciene Barbosa; Herminia Miño de Kaspar
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-08-18       Impact factor: 3.117

6.  Comparison of natamycin and voriconazole for the treatment of fungal keratitis.

Authors:  Namperumalsamy V Prajna; Jeena Mascarenhas; Tiruvengada Krishnan; P Ravindranath Reddy; Lalitha Prajna; Muthiah Srinivasan; C M Vaitilingam; Kevin C Hong; Salena M Lee; Stephen D McLeod; Michael E Zegans; Travis C Porco; Thomas M Lietman; Nisha R Acharya
Journal:  Arch Ophthalmol       Date:  2010-06

7.  [The German keratomycosis registry : Initial results of a multicenter survey].

Authors:  M Roth; L Daas; A Renner-Wilde; N Cvetkova-Fischer; M Saeger; M Herwig-Carl; M Matthaei; A Fekete; V Kakkassery; G Walther; M von Lilienfeld-Toal; C Mertens; J Lenk; J Mehlan; C Fischer; M Fuest; S Kroll; W Bayoudh; A Viestenz; A Frings; C R MacKenzie; E M Messmer; B Seitz; O Kurzai; G Geerling
Journal:  Ophthalmologe       Date:  2019-10       Impact factor: 1.059

8.  Recurrent Fungal Keratitis and Blepharitis Caused by Aspergillus flavus.

Authors:  Chia-Yi Lee; Yi-Ju Ho; Chi-Chin Sun; Hsin-Chiung Lin; Ching-Hsi Hsiao; David Hui-Kang Ma; Chi-Chun Lai; Hung-Chi Chen
Journal:  Am J Trop Med Hyg       Date:  2016-09-12       Impact factor: 2.345

Review 9.  Current perspectives on ophthalmic mycoses.

Authors:  Philip A Thomas
Journal:  Clin Microbiol Rev       Date:  2003-10       Impact factor: 26.132

10.  Clinical utility of voriconazole eye drops in ophthalmic fungal keratitis.

Authors:  Daoud Al-Badriyeh; Chin Fen Neoh; Kay Stewart; David C M Kong
Journal:  Clin Ophthalmol       Date:  2010-05-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.